The global generic pharmaceuticals contract manufacturing market is witnessing significant momentum as cost-efficiency, scalability, and quality assurance continue to drive demand from pharmaceutical companies worldwide. According to recent analysis, the market size was valued at USD 64.82 billion in 2023 and is projected to grow from USD 69.53 billion in 2024 to USD 127.46 billion by 2031....
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Ελληνικά
Tiếng Việt